Original Article Orthopedics
Association between SGLT2 inhibitors and emergency department revisits: evidence from adults with type 2 diabetes

Association between SGLT2 inhibitors and emergency department revisits: evidence from adults with type 2 diabetes

Authors

Lucas Zhang

Lucas Zhang

Karolinska University Hospital, Armenia

Mei Novak

Mei Novak

Mayo Clinic, Jamaica

Daniel Nasser

Daniel Nasser

Charité Berlin, Solomon Islands

Felix Farouk

Felix Farouk

King Fahad Medical City, Turks and Caicos Islands

Corresponding
Mariam Mueller

Mariam Mueller

Aga Khan University Hospital, Nicaragua

Published

July 26, 2024

Paper ID

PAP-000218

Status

Published

DOI

10.65712/tmj.test000476

Association between SGLT2 inhibitors and emergency department revisits: evidence from adults with type 2 diabetes

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Practice around SGLT2 inhibitors varies widely between centres. Methods: The primary outcome was emergency department revisits, assessed blind to allocation. Results: Serious adverse events were rare and similar between groups. Serious adverse events were rare and similar between groups. Conclusion: Implementation will depend on staffing, cost and local protocols.

Introduction

Guidelines make only a weak recommendation on SGLT2 inhibitors. Earlier studies of SGLT2 inhibitors were small or single-centre. Practice around SGLT2 inhibitors varies widely between centres. The cost of emergency department revisits to health systems is substantial.

Earlier studies of SGLT2 inhibitors were small or single-centre. emergency department revisits remains a leading cause of avoidable harm among adults with type 2 diabetes.

Practice around SGLT2 inhibitors varies widely between centres.

Guidelines make only a weak recommendation on SGLT2 inhibitors. Practice around SGLT2 inhibitors varies widely between centres. emergency department revisits remains a leading cause of avoidable harm among adults with type 2 diabetes.

Materials and Methods

Eligible participants were adults with type 2 diabetes. Missing data were handled with multiple imputation. We conducted a cross-sectional survey across 5 centres between 2015 and 2025. We conducted a cross-sectional survey across 9 centres between 2015 and 2024.

Eligible participants were adults with type 2 diabetes.

Results

emergency department revisits occurred in 20% of the intervention group versus 24% of controls. emergency department revisits occurred in 11% of the intervention group versus 36% of controls. emergency department revisits occurred in 10% of the intervention group versus 25% of controls. Effects were consistent across prespecified subgroups.

GroupnEventsRate %OR95% CI
Control8188133.40.430.55–1.26
Centre B16835.60.910.39–1.26
Control3495924.90.780.42–1.10
Intervention355112.00.850.37–1.13
Centre B2899032.00.640.32–1.1
Intervention3841.70.720.31–1.10
TABLE 1: Subgroup analysis
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Change in emergency department revisits
Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Trend in emergency department revisits
Shown for adults with type 2 diabetes; error bars are 95% confidence intervals.

emergency department revisits occurred in 16% of the intervention group versus 31% of controls. The adjusted odds ratio was 0.64 (95% CI 0.28 to 0.77). The adjusted odds ratio was 0.85 (95% CI 0.37 to 0.63). emergency department revisits occurred in 7% of the intervention group versus 28% of controls.

emergency department revisits occurred in 14% of the intervention group versus 20% of controls. Serious adverse events were rare and similar between groups.

Discussion

Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.

These findings suggest that SGLT2 inhibitors is associated with better emergency department revisits in adults with type 2 diabetes. Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.

Conclusions

SGLT2 inhibitors may be offered for adults with type 2 diabetes to improve emergency department revisits.

References

1. Mueller K, Nasser Y, et al. Telemedicine follow-up and emergency department revisits. Ann Intern Med. 2022;129(6):800-1060.

2. Mensah Z, Volkov L, et al. Early enteral nutrition and health-related quality of life. Pediatrics. 2024;346(1):380-1284.

3. Nasser K, Haddad U, et al. Early enteral nutrition and length of stay. Crit Care Med. 2016;296(6):548-1082.

4. Volkov A, Andersen O, et al. Pharmacist-led medication review and post-operative delirium. Diabetes Care. 2014;185(6):451-1199.

5. Ibrahim N, Volkov Y, et al. Delayed cord clamping and length of stay. Eur Heart J. 2010;176(1):96-1470.

6. Ibrahim V, Nakamura H, et al. An enhanced recovery pathway and ventilator-free days. JAMA. 2023;344(9):543-1185.

Appendices

The statistical analysis plan is in the online supplement.